James Thomas

435 total citations
24 papers, 316 citations indexed

About

James Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, James Thomas has authored 24 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in James Thomas's work include Breast Cancer Treatment Studies (6 papers), Ectopic Pregnancy Diagnosis and Management (4 papers) and Advanced Breast Cancer Therapies (3 papers). James Thomas is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Ectopic Pregnancy Diagnosis and Management (4 papers) and Advanced Breast Cancer Therapies (3 papers). James Thomas collaborates with scholars based in United Kingdom, United States and Switzerland. James Thomas's co-authors include T. Bourne, J. Michael Dixon, Lorna Renshaw, Raymond Reiser, Barbara C. O’Brien, Dana Faratian, E. Jane Macaskill, Andrew H. Sims, Timothy R. Wilson and Arran Turnbull and has published in prestigious journals such as PLoS ONE, Hepatology and Cancer Research.

In The Last Decade

James Thomas

22 papers receiving 299 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Thomas United Kingdom 7 132 94 67 60 56 24 316
Ashok Subramanian United Kingdom 9 21 0.2× 76 0.8× 75 1.1× 63 1.1× 57 1.0× 19 322
Maria Cioch Poland 10 90 0.7× 98 1.0× 29 0.4× 23 0.4× 48 0.9× 30 301
Dawn M. Grabrick United States 9 103 0.8× 237 2.5× 31 0.5× 83 1.4× 67 1.2× 13 411
Azhar Khan United Kingdom 11 165 1.3× 66 0.7× 35 0.5× 52 0.9× 14 0.3× 26 421
Mei‐Tzu C. Tang United States 10 66 0.5× 231 2.5× 24 0.4× 33 0.6× 109 1.9× 26 379
F. Clavel‐Chapelon France 7 100 0.8× 144 1.5× 10 0.1× 15 0.3× 30 0.5× 8 340
Kenneth C. Johnson Canada 6 74 0.6× 125 1.3× 24 0.4× 18 0.3× 55 1.0× 8 281
D Surekha India 12 61 0.5× 107 1.1× 26 0.4× 13 0.2× 50 0.9× 22 340
Yusuke Hara Japan 11 63 0.5× 78 0.8× 61 0.9× 28 0.5× 24 0.4× 30 383

Countries citing papers authored by James Thomas

Since Specialization
Citations

This map shows the geographic impact of James Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Thomas more than expected).

Fields of papers citing papers by James Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Thomas. The network helps show where James Thomas may publish in the future.

Co-authorship network of co-authors of James Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of James Thomas. A scholar is included among the top collaborators of James Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Thomas. James Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hemond, Christopher C., et al.. (2021). Exacerbation of Multiple Sclerosis by BRAF/MEK Treatment for Malignant Melanoma: The Central Vein Sign to Distinguish Demyelinating Lesions From Metastases. Journal of Investigative Medicine High Impact Case Reports. 9. 1605880791–1605880791. 4 indexed citations
2.
Cohan, Stanley, et al.. (2019). Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy. Multiple Sclerosis Journal - Experimental Translational and Clinical. 5(1). 2453244586–2453244586. 6 indexed citations
3.
Thomas, James, et al.. (2018). Direct-Acting Antiviral Therapy in Primary Care Following Non-Real Time, Remote Specialist Review - a Practical Solution to Scaling up HCV Therapy. Hepatology. 68. 1 indexed citations
4.
Thomas, James, AM Hanby, Sarah E. Pinder, et al.. (2017). Abstract P3-17-06: LORIS trial of active monitoring for DCIS: How does the online pathology eligibility review process work?. Cancer Research. 77(4_Supplement). P3–17. 3 indexed citations
5.
Howick, Jeremy, Claire Friedemann Smith, Maria Tsakok, et al.. (2016). Erratum: Are treatments more effective than placebos? A systematic review and meta-analysis (PLoS ONE (2015) 11:1 (e0147354) 10.1371/journal.pone.0147354)). PLoS ONE. 11. 2 indexed citations
6.
Hulikal, Narendra, et al.. (2014). An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response. Indian Journal of Cancer. 51(4). 587–587. 6 indexed citations
7.
Arthur, Laura, Arran Turnbull, Lorna Renshaw, et al.. (2014). Changes in PIK3CA mutation status are not associated with recurrence, metastatic disease or progression in endocrine-treated breast cancer. Breast Cancer Research and Treatment. 147(1). 211–219. 31 indexed citations
8.
Thomas, James & Tanya Monaghan. (2014). The respiratory system. Oxford University Press eBooks. 1 indexed citations
9.
Thomas, James, et al.. (2014). The paediatric assessment. Oxford University Press eBooks. 1 indexed citations
10.
Earl, Helena, David Cameron, JMS Bartlett, et al.. (2012). Abstract OT3-3-09: ARTemis trial - randomised trial with neo-adjuvant chemotherapy for patients with early breast cancer. Cancer Research. 72(24_Supplement). OT3–3.
11.
Jones, Anna‐Marie, et al.. (2009). Evaluation of bowel cancer registration data in England, 1996–2004. British Journal of Cancer. 101(8). 1269–1273. 6 indexed citations
12.
Murray, Juliette, Lorna Renshaw, Linda Williams, et al.. (2008). A randomised study of the effects of letrozole and anastrozole on oestrogen receptor positive breast cancers in postmenopausal women. Breast Cancer Research and Treatment. 114(3). 495–501. 16 indexed citations
13.
Renshaw, Lorna, et al.. (2007). Effects of fulvestrant 750 mg in premenopausal women with oestrogen-receptor-positive primary breast cancer. European Journal of Cancer. 44(3). 391–399. 55 indexed citations
14.
Thomas, James, et al.. (2004). The conservative management of interstitial pregnancy. BJOG An International Journal of Obstetrics & Gynaecology. 111(11). 1283–1288. 108 indexed citations
15.
Condous, G., James Thomas, E. Okaro, & T. Bourne. (2003). Placental site trophoblastic tumor masquerading as an ovarian ectopic pregnancy. Ultrasound in Obstetrics and Gynecology. 21(5). 504–506. 11 indexed citations
16.
Condous, G., et al.. (2003). Single-dose methotrexate in the treatment of cornual pregnancies diagnosed with ultrasound in the first trimester. Ultrasound in Medicine & Biology. 29(5). S52–S52. 3 indexed citations
17.
Thomas, James, et al.. (1991). Primary peritoneal pregnancy: a case report.. PubMed. 83(7). 635–7. 6 indexed citations
18.
Thomas, James, et al.. (1991). Prospective study of quantitative aspects of audit in a large general histopathology laboratory.. Journal of Clinical Pathology. 44(11). 928–931. 1 indexed citations
19.
Brandstetter, Robert D., et al.. (1982). Hypoxemia following thoracentesis.. PubMed. 11(3). 216–216. 1 indexed citations
20.
Thomas, James, et al.. (1969). [Some reflextions apropos of 45 cases of malarial comas confirmed parasitologically in children under 6 years old].. PubMed. 27(6). 606–14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ashok Subramanian Breakdown of academic impact, for papers by Maria Cioch Breakdown of academic impact, for papers by Dawn M. Grabrick Breakdown of academic impact, for papers by Azhar Khan Breakdown of academic impact, for papers by Mei‐Tzu C. Tang Breakdown of academic impact, for papers by F. Clavel‐Chapelon Breakdown of academic impact, for papers by Kenneth C. Johnson Breakdown of academic impact, for papers by D Surekha Breakdown of academic impact, for papers by Yusuke Hara
Rankless by CCL
2026